Relative Bioavailability Study of Lipidil® Supra (Fenofibrate 160mg) Versus SYO-0805 (Fenofibrate 65mg)

NCT01353404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Sequence 1
DRUG: Sequence 2
DRUG: Seqeunce 3
DRUG: Sequence 4
DRUG: Sequence 5
DRUG: Sequence 6

Sponsor

Samyang Biopharmaceuticals Corporation